Australia TGA Regulatory Approval Process for Medical Devices

The chart shown illustrates the TGA approval process in Australia and is available for download in PDF format. Also includes a timeline of expected approval.

The Australian TGA medical device approval process explained

To obtain access to the Australian market, medical device and IVD manufacturers will need to include their product in the Australian Register of Therapeutic Goods (ARTG), regulated by the Therapeutic Goods Administration (TGA). If you have already acquired the European CE Marking, the TGA approval process will be easier since the Australia recognizes CE Marking.

Step 1
Determine classification using Schedule 2 of the Australian Therapeutic Goods (Medical Devices) Regulations 2002. If a device has European CE Marking, the classification will likely be the same. A CE Marking certificate from a Notified Body is generally accepted by the Therapeutic Goods Administration (TGA) as part of your registration.

Step 2
If you have no local presence in Australia, appoint an Australian Sponsor. The Sponsor facilitates your device registration, acts as the liaison between the manufacturer and the TGA, and the Sponsor’s name must appear on your device and labeling.

Step 3
Have current Technical File or Design Dossier (Class III) and Declaration of Conformity ready for submission.

Step 5
Class III devices will undergo a Level 2 Application Audit. The design dossier is reviewed by the TGA.

Step 6
For all classes, the Australian Sponsor submits Medical Device Application online in eBS system. The Application should include Intended Purpose statement, classification and GMDN code. Pay application fee.

Step 7
The TGA will approve or reject your application. If approved by the TGA, an Australian Register of Therapeutic Goods (ARTG) listing number will be issued (ARTG Certificate of Inclusion) and your listing will be included in teh ARTG database on the TGA website.

Step 8
You may now begin marketing your device in Australia. Registrations do not expire as long as you do not make changes to the device that would invalidate the ARTG listing, a current CE Marketing certificate (if applicale) is on file with the TGA, and the annual ARTG listing fee is paid.

IMPORTANT NOTE: This chart demonstrates the route to compliance in Australia for devices that already have CE Marking and which do not include animal tissue, human blood/plasma derivaives, or medicinal components.

Within the UL family of companies we provide a broad portfolio of offerings to all the medical device industries. This includes certification, Notified Body and consultancy services. In order to protect and prevent any conflict of interest, perception of conflict of interest and protection of both our brand and our customers brands, UL is unable to provide consultancy services to Notified Body or MDSAP customers. UL has processes in place to identify and manage any potential conflicts of interest and maintain impartiality. Learn more here.